title: Anticoagulation in cirrhosis patients: what don't we know?
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Northup
authors.forename: Nicolas M
authors.initials: NM
authors.lastname: Intagliata
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects*; D016903:Drug Monitoring / Q000379:methods; D017984:Enoxaparin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D004932:Esophageal and Gastric Varices / Q000097:blood / Q000209:etiology*; D015951:Factor Xa / Q000378:metabolism; D065427:Factor Xa Inhibitors; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications*; D008111:Liver Function Tests; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D000990:Antithrombin III; D015951:Factor Xa